Literature DB >> 29926732

Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.

Amanda B Macedo1, Rachel S Resop1, Laura J Martins2, Matthew A Szaniawski2, Eric S Sorensen1, Adam M Spivak3, Douglas F Nixon1, R Brad Jones1, Vicente Planelles2, Alberto Bosque1.   

Abstract

Primary cell models of human immunodeficiency virus (HIV) latency have become tools to both understand the mechanisms involved in establishment of latency and test preclinical strategies toward HIV-1 cure. These models rely on infection of CD4 T cells from healthy donors. As such, these models provide an opportunity to explore the role of biological sex, age, and HIV status on establishment and reactivation of latent HIV in vitro. We have used an established primary cell model of latency based on the generation of latently infected central memory CD4 T cells with the CXCR4 strain HIV-1NL4-3 to address whether these variables influence (i) HIV-1NL4-3 replication, (ii) establishment of latency, and (iii) latency reversal in CD4 T cells. Our results indicate that replication of HIV-1NL4-3, but not establishment of latency, is influenced by the age of female, but not male, donors. Moreover, the frequency of latently infected cells in this model is directly correlated with levels of productive infection in both male and female donors independent of age. We did not find differences in the ability of five different latency-reversing agents to reactivate latent HIV-1NL4-3. Finally, we have found that this model can be generated using cells from aviremic participants. In conclusion, we have further characterized the central memory T cell model of latency regarding biological sex and age and demonstrated that this model is suitable for use with cells isolated from aviremic participants, opening the opportunity to use this primary cell model to address cure approaches, including shock and kill, in HIV-infected individuals.

Entities:  

Keywords:  HIV; age; biological sex; latency; primary cell models; reservoirs

Mesh:

Substances:

Year:  2018        PMID: 29926732      PMCID: PMC6152854          DOI: 10.1089/AID.2018.0098

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  58 in total

1.  A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes.

Authors:  Gautam K Sahu; Kyeongeun Lee; Jiaxiang Ji; Vivian Braciale; Samuel Baron; Miles W Cloyd
Journal:  Virology       Date:  2006-08-17       Impact factor: 3.616

Review 2.  Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV.

Authors:  Youry Kim; Jenny L Anderson; Sharon R Lewin
Journal:  Cell Host Microbe       Date:  2018-01-10       Impact factor: 21.023

3.  Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.

Authors:  Thomas D Zaikos; Mark M Painter; Nadia T Sebastian Kettinger; Valeri H Terry; Kathleen L Collins
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

4.  Cutting edge: in vivo induction of integrated HIV-1 expression by mycobacteria is critically dependent on Toll-like receptor 2.

Authors:  André Báfica; Charles A Scanga; Marco L Schito; Sara Hieny; Alan Sher
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

5.  CpG oligodeoxynucleotides activate HIV replication in latently infected human T cells.

Authors:  Carsten Scheller; Anett Ullrich; Kirsty McPherson; Barbara Hefele; Johanna Knöferle; Stefan Lamla; Anke R M Olbrich; Hartmut Stocker; Keikawus Arasteh; Volker ter Meulen; Axel Rethwilm; Eleni Koutsilieri; Ulf Dittmer
Journal:  J Biol Chem       Date:  2004-03-11       Impact factor: 5.157

6.  Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.

Authors:  Hung-Chih Yang; Sifei Xing; Liang Shan; Karen O'Connell; Jason Dinoso; Anding Shen; Yan Zhou; Cynthia K Shrum; Yefei Han; Jun O Liu; Hao Zhang; Joseph B Margolick; Robert F Siliciano
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

7.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

8.  Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

Authors:  T W Chun; D Engel; M M Berrey; T Shea; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

9.  Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.

Authors:  Cory H White; Bastiaan Moesker; Nadejda Beliakova-Bethell; Laura J Martins; Celsa A Spina; David M Margolis; Douglas D Richman; Vicente Planelles; Alberto Bosque; Christopher H Woelk
Journal:  PLoS Pathog       Date:  2016-11-29       Impact factor: 6.823

10.  Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.

Authors:  Gregory M Laird; Evelyn E Eisele; S Alireza Rabi; Jun Lai; Stanley Chioma; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

View more
  15 in total

1.  The Cultured TCM Model of HIV Latency.

Authors:  Alberto Bosque
Journal:  Methods Mol Biol       Date:  2022

2.  Sex biases in infectious diseases research.

Authors:  Santosh Dhakal; Sabal Chaulagain; Sabra L Klein
Journal:  J Exp Med       Date:  2022-05-05       Impact factor: 17.579

Review 3.  Sexual dimorphism in HIV-1 infection.

Authors:  Anne Rechtien; Marcus Altfeld
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

4.  Micro RNA Targets in HIV Latency: Insights into Novel Layers of Latency Control.

Authors:  Ashley I Heinson; Jeongmin Woo; Amey Mukim; Cory H White; Bastiaan Moesker; Alberto Bosque; Celsa A Spina; Christopher H Woelk; Ben D Macarthur; Nadejda Beliakova-Bethell
Journal:  AIDS Res Hum Retroviruses       Date:  2020-11-10       Impact factor: 2.205

5.  Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Ex Vivo Reservoirs.

Authors:  Yanqin Ren; Szu Han Huang; Amanda B Macedo; Adam R Ward; Winiffer D Conce Alberto; Thais Klevorn; Louise Leyre; Dennis C Copertino; Talia M Mota; Dora Chan; Ronald Truong; Thomas Rohwetter; Paul Zumbo; Friederike Dündar; Doron Betel; Colin Kovacs; Erika Benko; Alberto Bosque; R Brad Jones
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

Review 6.  Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists.

Authors:  Amanda B Macedo; Camille L Novis; Alberto Bosque
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

7.  The Intact Non-Inducible Latent HIV-1 Reservoir is Established In an In Vitro Primary TCM Cell Model of Latency.

Authors:  Indra Sarabia; Szu-Han Huang; Adam R Ward; R Brad Jones; Alberto Bosque
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

8.  Activation of the Anti-Oxidative Stress Response Reactivates Latent HIV-1 Through the Mitochondrial Antiviral Signaling Protein Isoform MiniMAVS.

Authors:  Indra Sarabia; Camille L Novis; Amanda B Macedo; Hiroshi Takata; Racheal Nell; Juyeon C Kakazu; Robert L Furler; Binita Shakya; Heidi L Schubert; Christopher P Hill; Ana Beatriz DePaula-Silva; Adam M Spivak; Lydie Trautmann; Vicente Planelles; Alberto Bosque
Journal:  Front Immunol       Date:  2021-06-14       Impact factor: 7.561

9.  Long non-coding RNAs and latent HIV - A search for novel targets for latency reversal.

Authors:  Wim Trypsteen; Cory H White; Amey Mukim; Celsa A Spina; Ward De Spiegelaere; Steve Lefever; Vicente Planelles; Alberto Bosque; Christopher H Woelk; Linos Vandekerckhove; Nadejda Beliakova-Bethell
Journal:  PLoS One       Date:  2019-11-11       Impact factor: 3.240

10.  Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents.

Authors:  Eric S Sorensen; Amanda B Macedo; Rachel S Resop; J Natalie Howard; Racheal Nell; Indra Sarabia; Daniel Newman; Yanqin Ren; R Brad Jones; Vicente Planelles; Adam M Spivak; Alberto Bosque
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.